Factor Therapeutics
(ASX:FTT)

Health & Biotech

RAMCap wants to turn Factor Therapeutics into a hedge fund business

April 3, 2020 | Nick Sundich

Health & Biotech

Check up: The COVID-crisis strikes leaving just 9 stocks in the black

March 18, 2020March 18, 2020 | Rachel Williamson

Health & Biotech

My bank balance is bigger than yours: biotech quarterlies

January 28, 2020January 28, 2020 | Rachel Williamson

Health & Biotech

9 of the most interesting biotech bosses in the game today: part 1

December 30, 2019December 31, 2019 | Rachel Williamson

News

Corporate: Factor Therapeutics still looking for its next opportunity

October 2, 2019 | Nick Sundich

Health & Biotech

When is the right time for a biotech to try and woo big pharma?

September 20, 2019September 19, 2019 | Daniel Paproth

Health & Biotech

Health: Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer

April 24, 2019April 24, 2019 | Sam Jacobs

News

Corporate: Oilex wants to put its legal ruckus with Indian partner to bed

April 1, 2019April 1, 2019 | Angela East

News

Weststar wins $2.7m in precast concrete contracts

March 28, 2019 | Angela East

Check-up: What’s happening with the ASX small cap health stocks?

March 14, 2019March 13, 2019 | Daniel Paproth

Health & Biotech

‘Mice are a failed experiment’: Why you shouldn’t get revved up about pre-clinical trials

March 11, 2019March 11, 2019 | Daniel Paproth

News

Kick Back: The 10 biggest stories you might have missed on Stockhead this week

March 8, 2019June 26, 2019 | Peter Farquhar